DE2528847A1 - 1-aethyl-4-(halogenphenyl)benzole und verfahren zu ihrer herstellung - Google Patents
1-aethyl-4-(halogenphenyl)benzole und verfahren zu ihrer herstellungInfo
- Publication number
- DE2528847A1 DE2528847A1 DE19752528847 DE2528847A DE2528847A1 DE 2528847 A1 DE2528847 A1 DE 2528847A1 DE 19752528847 DE19752528847 DE 19752528847 DE 2528847 A DE2528847 A DE 2528847A DE 2528847 A1 DE2528847 A1 DE 2528847A1
- Authority
- DE
- Germany
- Prior art keywords
- benzene
- ethyl
- formula
- compounds
- fluorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 title description 33
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 8
- 150000001555 benzenes Chemical class 0.000 claims description 6
- 125000005059 halophenyl group Chemical group 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- BOWKEZIHDUGWRW-UHFFFAOYSA-N 1-chloro-4-(4-ethylphenyl)benzene Chemical compound C1=CC(CC)=CC=C1C1=CC=C(Cl)C=C1 BOWKEZIHDUGWRW-UHFFFAOYSA-N 0.000 claims description 3
- KLXSCTGIQJRWFL-UHFFFAOYSA-N 1-ethyl-4-(2-fluorophenyl)benzene Chemical compound C1=CC(CC)=CC=C1C1=CC=CC=C1F KLXSCTGIQJRWFL-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- XMUPAYYXUAMWIR-UHFFFAOYSA-N 1-chloro-2-(4-ethylphenyl)benzene Chemical compound C1=CC(CC)=CC=C1C1=CC=CC=C1Cl XMUPAYYXUAMWIR-UHFFFAOYSA-N 0.000 claims description 2
- XEZNQQZDLUYHOA-UHFFFAOYSA-N 1-ethyl-4-(4-fluorophenyl)benzene Chemical compound C1=CC(CC)=CC=C1C1=CC=C(F)C=C1 XEZNQQZDLUYHOA-UHFFFAOYSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 description 11
- 239000000460 chlorine Substances 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229960004676 antithrombotic agent Drugs 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- KQNNNDZVEYLTHF-UHFFFAOYSA-N 1-[4-(2-chlorophenyl)phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1C1=CC=CC=C1Cl KQNNNDZVEYLTHF-UHFFFAOYSA-N 0.000 description 2
- YETULFFXNIHQLK-UHFFFAOYSA-N 1-ethynyl-4-(2-fluorophenyl)benzene Chemical compound FC1=CC=CC=C1C1=CC=C(C#C)C=C1 YETULFFXNIHQLK-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000004968 inflammatory condition Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- NPGUSEJJJVVVME-UHFFFAOYSA-N 1-[4-(4-chlorophenyl)phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1C1=CC=C(Cl)C=C1 NPGUSEJJJVVVME-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical class C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 229960004193 dextropropoxyphene Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000005194 ethylbenzenes Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000006215 rectal suppository Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C25/00—Compounds containing at least one halogen atom bound to a six-membered aromatic ring
- C07C25/18—Polycyclic aromatic halogenated hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/35—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction
- C07C17/354—Preparation of halogenated hydrocarbons by reactions not affecting the number of carbon or of halogen atoms in the reaction by hydrogenation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48587674A | 1974-07-05 | 1974-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2528847A1 true DE2528847A1 (de) | 1976-01-22 |
Family
ID=23929779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19752528847 Pending DE2528847A1 (de) | 1974-07-05 | 1975-06-27 | 1-aethyl-4-(halogenphenyl)benzole und verfahren zu ihrer herstellung |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5134132A (enExample) |
| AT (1) | AT336005B (enExample) |
| AU (1) | AU8262975A (enExample) |
| BE (1) | BE830718A (enExample) |
| BG (1) | BG24402A3 (enExample) |
| CS (1) | CS184785B2 (enExample) |
| DD (1) | DD120426A5 (enExample) |
| DE (1) | DE2528847A1 (enExample) |
| DK (1) | DK301175A (enExample) |
| ES (1) | ES439164A1 (enExample) |
| FR (1) | FR2276812A1 (enExample) |
| IL (1) | IL47588A0 (enExample) |
| NL (1) | NL7507713A (enExample) |
| PH (1) | PH10655A (enExample) |
| SE (1) | SE7507566L (enExample) |
| SU (1) | SU596158A3 (enExample) |
| ZA (1) | ZA754276B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3270906D1 (en) * | 1982-01-14 | 1986-06-05 | Merck Patent Gmbh | Liquid crystal mixtures |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5079840A (enExample) * | 1973-11-20 | 1975-06-28 |
-
1975
- 1975-06-17 JP JP50073632A patent/JPS5134132A/ja active Pending
- 1975-06-27 PH PH17327A patent/PH10655A/en unknown
- 1975-06-27 BE BE1006746A patent/BE830718A/xx unknown
- 1975-06-27 IL IL47588A patent/IL47588A0/xx unknown
- 1975-06-27 DE DE19752528847 patent/DE2528847A1/de active Pending
- 1975-06-27 NL NL7507713A patent/NL7507713A/xx unknown
- 1975-06-30 FR FR7520491A patent/FR2276812A1/fr not_active Withdrawn
- 1975-07-01 AU AU82629/75A patent/AU8262975A/en not_active Expired
- 1975-07-01 SE SE7507566A patent/SE7507566L/xx unknown
- 1975-07-01 DD DD186997A patent/DD120426A5/xx unknown
- 1975-07-03 ZA ZA754276A patent/ZA754276B/xx unknown
- 1975-07-03 DK DK301175A patent/DK301175A/da unknown
- 1975-07-04 BG BG030459A patent/BG24402A3/xx unknown
- 1975-07-04 CS CS7500004772A patent/CS184785B2/cs unknown
- 1975-07-04 AT AT516375A patent/AT336005B/de not_active IP Right Cessation
- 1975-07-04 SU SU752151514A patent/SU596158A3/ru active
- 1975-07-04 ES ES439164A patent/ES439164A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ATA516375A (de) | 1976-08-15 |
| NL7507713A (nl) | 1976-01-07 |
| ZA754276B (en) | 1977-02-23 |
| BG24402A3 (en) | 1978-02-10 |
| IL47588A0 (en) | 1975-08-31 |
| BE830718A (fr) | 1975-12-29 |
| CS184785B2 (en) | 1978-09-15 |
| FR2276812A1 (fr) | 1976-01-30 |
| JPS5134132A (en) | 1976-03-23 |
| SU596158A3 (ru) | 1978-02-28 |
| SE7507566L (sv) | 1976-01-07 |
| DD120426A5 (enExample) | 1976-06-12 |
| DK301175A (da) | 1976-01-06 |
| AU8262975A (en) | 1977-01-06 |
| ES439164A1 (es) | 1977-03-01 |
| PH10655A (en) | 1977-07-27 |
| AT336005B (de) | 1977-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69016821T2 (de) | Behandlungsmittel gegen Osteoarthritis. | |
| DE2351412C2 (de) | 2,2-Disubstituierte 1-Oxo-5-indanyloxy-carbonsäuren, Verfahren zu deren Herstellung und Spaltung racemischer Gemische, sowie diese enthaltende Arzneimittel | |
| DE2147111A1 (de) | Substituierte Benzoylpropionsäuren enthaltende Mittel und ihre Verwendung | |
| DE2065635A1 (de) | Neue tricyclische verbindungen | |
| EP0535420A1 (de) | Acylale von Imidazol-5-carbonsäurederivaten, als Angiotensin II Inhibitoren | |
| DE2160148C2 (de) | Arzneimittel und bestimmte Sulfoxide als solche | |
| DE2302866C2 (de) | N-substituierte 4-nitrophenyl-2,6-dialkyl-1,4-dihydropyridin-3,5-dicarboxylate | |
| DE68911776T2 (de) | Konjugierte Oxybutenolide zur Behandlung von Ulcera. | |
| DE2157272C3 (de) | Verwendung von bis-(p-Chlorphenoxy)acetylharnstoff | |
| DE68913389T2 (de) | Zyklische schwefelhaltige Verbindungen. | |
| EP0100516B1 (de) | 3-Beta-(3'-(Carboxypropionyloxy))-ursa-9(11),12-dien-28-carbonsäure sowie ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2528847A1 (de) | 1-aethyl-4-(halogenphenyl)benzole und verfahren zu ihrer herstellung | |
| DE2035517C3 (de) | 11 -Aminoalkylidenmorphanthridine sowie Verfahren zu deren Herstellung | |
| DE69023045T2 (de) | Carboxamidderivate. | |
| DE2237832A1 (de) | Verfahren zur herstellung von 4hydroxymethyl-1-keto-1,2-dihydrophthalazin | |
| DD283375A5 (de) | Verwendung des tromethamin-salzes von 1-methyl-beta-oxo-alpha-(phenylcarbamoyl);2-pyrrol-propionitril | |
| DE1934392C3 (de) | Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung | |
| DE2232827A1 (de) | Neue steroide und verfahren zu ihrer herstellung | |
| DE2434919A1 (de) | Phosphin- und phosphit-goldkomplexe von mercaptobenzoesaeure und substituierten thiophenolen und arzneimittel | |
| DE2614138C2 (de) | Benzo[b]thienylcarbonylpropyl- bzw. Butylamine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| CH645351A5 (de) | O- und m-methylthiophenylaethylamin, verfahren zu ihrer herstellung und pharmazeutische zubereitungen. | |
| DE2437147A1 (de) | Phosphin- und phosphit-goldkomplexe und arzneimittel | |
| CH635101A5 (en) | Process for the preparation of novel pyrido[1,2-a]pyrimidine derivatives, their optically active isomers and physiologically tolerable salts | |
| AT281840B (de) | Verfahren zur Herstellung von neuen 1,4-Benzodiazepinen bzw. von Salzen hievon | |
| DE1468067C3 (de) | alpha, alpha-dialkylsubstKulerte 1-Naphthylesslgsauren, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |